---
title: "Vivanza Biosciences Ltd (530057) — Share Price, Financials & Analysis"
symbol: "530057"
company: "Vivanza Biosciences Ltd"
canonical: "https://tapetide.com/stocks/530057"
isin: "INE984E01035"
nse_symbol: "VIVANZABIOSCIENCESLTD"
bse_code: "530057"
sector: "Healthcare"
industry: "Pharmaceuticals"
market_cap_cr: 7.5
generated_at: "2026-09-13T18:48:15.246Z"
---

# Vivanza Biosciences Ltd (530057)

Canonical page: https://tapetide.com/stocks/530057

## Company

- **NSE Symbol:** VIVANZABIOSCIENCESLTD
- **BSE Code:** 530057
- **ISIN:** INE984E01035
- **Sector:** Healthcare
- **Industry:** Pharmaceuticals
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Face Value:** ₹1
- **F&O Eligible:** No
- **Website:** vivanzabiosciences.com

## About

Incorporated in 2016, Vivanza Biosciences Ltd is in the business of providing medicines and healthcare solutions[1]

## Latest Price

## Key Fundamentals

Observed at 2026-09-11T04:50:55.148016Z.

- **Market Cap:** ₹7.5 Cr
- **Classification:** Microcap
- **P/E (reported):** 17.1
- **EPS (TTM):** ₹0.12
- **EPS (reported):** ₹0.08
- **Book Value:** ₹1.09
- **Price to Book:** 1.73
- **Dividend Yield:** 0%
- **ROE:** 9.05%
- **ROCE:** 15.72%
- **Debt to Equity:** 2
- **Revenue (yearly):** ₹116 Cr
- **Net Income:** ₹0.4 Cr
- **EBITDA:** ₹0.8 Cr
- **52-Week High:** ₹2.72
- **52-Week Low:** ₹1.52
- **RSI (14):** 54.61

## Tapetide Score

- **Score:** 47 / 100
- **Score date:** 2026-09-04
- **Archetype:** Weak and Under Pressure
- **What it means:** Weak financials are the defining feature, and neither the valuation nor the trend reading is strong enough to offset them. Worth reading the risk flags and recent filings closely before anything else.
- **Pillar profile:** Quality: Weak · Valuation: Expensive · Momentum: Falling
- **Percentile:** 35.6 (of 4473 scored stocks)
- **Confidence:** 100%
- **Data coverage:** 100%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 25.12 | 9% |
| growth | 98.9 | 9% |
| momentum | 34.19 | 12% |
| ownership | 50 | 24% |
| quality | 37.37 | 22% |
| valuation | 46.33 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Debtor days have improved from 196 to 39.0 days.

### Weaknesses

- Promoter holding is low: 20.0%
- Company has a low return on equity of 2.11% over last 3 years.
- Company might be capitalizing the interest cost
- Promoter holding has decreased over last 3 years: -27.8%

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | -3.2% | -226.47% | -204.45% |
| ebitda margin growth | 250% | -118.2% | -81.84% | -89.02% |
| net income growth | 150% | -157.14% | -13% | 37% |
| revenue growth | 51.56% | — | 87% | 64% |
| roce | -226.09% | -464.73% | 3.83% | 11.85% |
| roe | -133.33% | -153.2% | 1.28% | -5.04% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 7.62 | 6.56 | 4.42 | 2.44 | 3 | 1.5 | 0.48 | 8.94 | 55.36 | 45.25 | 6.36 | 9.29 |
| Expenses | 7.3 | 6.27 | 4.56 | 2.08 | 2.89 | 1.37 | 1.44 | 8.79 | 54.75 | 45.04 | 6.59 | 9.36 |
| Operating Profit | 0.32 | 0.29 | -0.14 | 0.36 | 0.11 | 0.13 | -0.96 | 0.15 | 0.61 | 0.21 | -0.23 | -0.07 |
| OPM % | 4.2 | 4.42 | -3.17 | 14.75 | 3.67 | 8.67 | -200 | 1.68 | 1.1 | 0.46 | -3.62 | -0.75 |
| Other Income | 0.05 | 0.02 | -0.03 | 0 | 0 | 0.01 | 0.05 | 0.02 | 0.01 | 0.08 | 0.01 | 0.37 |
| Interest | 0.11 | 0.1 | 0.09 | 0.09 | 0.09 | 0.09 | 0.08 | 0.08 | 0.05 | 0.09 | 0.07 | 0.11 |
| Depreciation | 0 | 0 | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.01 | 0.01 |
| Profit before tax | 0.26 | 0.21 | -0.27 | 0.27 | 0.02 | 0.05 | -0.99 | 0.09 | 0.57 | 0.2 | -0.3 | 0.18 |
| Tax % | 0 | 0 | 55.56 | 0 | 0 | 0 | 1.01 | 0 | 0 | 0 | 50 | 22.22 |
| Net Profit | 0.26 | 0.21 | -0.41 | 0.27 | 0.02 | 0.04 | -1 | 0.09 | 0.56 | 0.2 | -0.45 | 0.15 |
| EPS in Rs | 0.06 | 0.05 | -0.1 | 0.07 | 0 | 0.01 | -0.25 | 0.02 | 0.14 | 0.05 | -0.11 | 0.04 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 6 | 3 | 10 | 10 | 10 | 18 | 28 | 7 | 116 | 116 |
| Expenses | 6 | 3 | 10 | 10 | 10 | 17 | 27 | 8 | 115 | 116 |
| Operating Profit | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 1 |
| OPM % | 9 | -0.8 | -3.6 | 0.9 | -0.6 | 3.8 | 3.9 | -4.9 | 0.6 | 0.5 |
| Other Income | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 0 | 0 | 0 | 0 | 0 | 1 | 1 | -1 | 1 | 1 |
| Tax % | 13 | 0 | 0 | 42 | 0 | 17 | 21 | 2 | 27 | — |
| Net Profit | 0 | 0 | 0 | 0 | 0 | 1 | 1 | -1 | 0 | 0 |
| EPS in Rs | 0.05 | -0.11 | -0.05 | 0.02 | 0.08 | 0.15 | 0.14 | -0.17 | 0.1 | 0.12 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 |
| Reserves | 0 | 0 | -1 | -1 | -1 | -1 | 0 | 1 | 0 | 0 |
| Borrowings | 1 | 1 | 1 | 0 | 0 | 6 | 8 | 5 | 9 | 10 |
| Other Liabilities | 3 | 5 | 6 | 9 | 5 | 7 | 10 | 10 | 4 | 8 |
| Total Liabilities | 7 | 10 | 11 | 12 | 8 | 16 | 22 | 20 | 16 | 22 |
| Fixed Assets | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 5 | 8 | 9 | 10 | 6 | 13 | 20 | 17 | 14 | 20 |
| Total Assets | 7 | 10 | 11 | 12 | 8 | 16 | 22 | 20 | 16 | 22 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | -2 | 0 | 1 | 3 | -3 | 2 | -1 | 2 | -2 | -3 |
| Cash from Investing Activity | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing Activity | 0 | -1 | -1 | -3 | 3 | -2 | 1 | -2 | 2 | 3 |
| Net Cash Flow | 0 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Free Cash Flow | -2 | 0 | 1 | 3 | -3 | 2 | -1 | 2 | -3 | -3 |
| CFO/OP | 668 | -15 | -4300 | -876 | -3367 | -4117 | -124 | 203 | 692 | -328 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 267 | 287 | 782 | 250 | 231 | 275 | 256 | 151 | 398 | 39 |
| Inventory Days | 215 | 150 | 309 | 38 | 26 | 92 | 55 | 28 | 121 | 11 |
| Days Payable | 304 | 319 | 878 | 319 | 154 | 207 | 211 | 116 | 140 | 23 |
| Cash Conversion Cycle | 178 | 118 | 213 | -32 | 103 | 160 | 99 | 64 | 379 | 27 |
| Working Capital Days | 332 | 237 | 469 | 109 | 104 | 103 | 50 | 44 | 154 | 7 |
| ROCE % | -10 | 13 | 0 | 6 | 17 | 12 | 11 | 10 | -3 | 6 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 47.29% | 44.9% | 43.24% | 40.05% | 39.86% | 20.02% | 20.02% | 20.02% | 20.02% | 20.02% | 20.02% | 20.02% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 6.23% | 9.06% | 13.82% | 45.01% | 51.05% | 71.21% | 73.69% | 73.36% | 73.34% | 73.42% | 73.34% | 73.49% |
| Others | 46.48% | 46.04% | 42.94% | 14.94% | 9.09% | 8.77% | 6.29% | 6.62% | 6.64% | 6.56% | 6.64% | 6.49% |
| No. of Shareholders | 5039 | 5937 | 6992 | 16941 | 16701 | 20635 | 20833 | 20458 | 20170 | 19822 | 19461 | 19254 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Buy
- **Buy / Neutral / Sell:** 10 / 6 / 3

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 1.79 | Buy |
| EMA (10) | 1.82 | Buy |
| SMA (20) | 1.79 | Buy |
| EMA (20) | 1.81 | Buy |
| SMA (50) | 1.84 | Buy |
| EMA (50) | 1.83 | Buy |
| SMA (100) | 1.86 | Buy |
| EMA (100) | 1.87 | Buy |
| SMA (200) | 1.97 | Sell |
| EMA (200) | 1.94 | Sell |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 55.18 | Neutral |
| MACD (12,26,9) | 0 | Buy |
| Stochastic (14,3,3) | 55.56 | Neutral |
| ADX (14) | 13.39 | Neutral |
| Williams %R (14) | -29.63 | Neutral |
| ATR (14) | 0.09 | High Volatility |
| ROC (12) | 3.85 | Buy |
| Stoch RSI (14) | 88.68 | Sell |
| UO (7,14,28) | 50.67 | Neutral |

## Filings & Documents

### Other Documents

| Date | Document |
| --- | --- |
| 9 Apr - Yearly promoter disclosure filed under SEBI Regulation 31(4) for year ended 31 March 2026. | [Disclosures Under Regulation 31(4) Of SEBI (SAST) Regulations, 2011 9 Apr - Yearly promoter disclosure filed under SEBI Regulation 31(4) for year ended 31 March 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a7d2c349-d1f8-4828-b049-11c3658e9d68.pdf) |
| 9 Apr - Company confirms it is not a Large Corporate as of 31 March 2026; no initial disclosure required. | [Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 9 Apr - Company confirms it is not a Large Corporate as of 31 March 2026; no initial disclosure required.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/655c65a3-f43b-4239-b366-e1acaa6ce391.pdf) |
| 7 May - Regulation 23(9) disclosure not applicable for quarter and year ended 31 March 2026. | [Non Applicability Of Related Party Transaction Under Regulation 23(9) Of SEBI (LODR) Regulations, 2015 For The Quarter And Year Ended 31St March, 2026 7 May - Regulation 23(9) disclosure not applicable for quarter and year ended 31 March 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/ff2ba028-a5af-426d-bab3-589c564b48a2.pdf) |
| 7 May - Board approved FY26 audited results; noted director and company secretary resignations, and committee reconstitution. | [Board Meeting Outcome for Audited Financial Results For The Quarter And Year Ended On 31St March, 2026 7 May - Board approved FY26 audited results; noted director and company secretary resignations, and committee reconstitution.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/1bd90e39-de11-47de-a798-2d33918dd06d.pdf) |
| 7 May - Board approved audited FY26 results and noted director, company secretary resignations; committees reconstituted on 7 May 2026. | [Results- Quarterly And Year To End Dated 31St March 2026 7 May - Board approved audited FY26 results and noted director, company secretary resignations; committees reconstituted on 7 May 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/23246650-c61f-4cde-9ffd-5cb0d7c5ee81.pdf) |
| 7 Aug 2025 - Unaudited Q1 2025 financials filed by Resolution Professional amid ongoing insolvency process. | [Submission Of Unaudited Financial Results Of Dion Global Solutions Ltd. For The Quarter Ended 30.06.2025 7 Aug 2025 - Unaudited Q1 2025 financials filed by Resolution Professional amid ongoing insolvency process.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/11599676-4a86-48f8-8568-0f8f992d2f9d.pdf) |
| 7 Apr - Regulation 74(5) compliance certificate for quarter ended 31 March 2026; no dematerialised share certificates reported. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 7 Apr - Regulation 74(5) compliance certificate for quarter ended 31 March 2026; no dematerialised share certificates reported.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/914d3687-3299-45fe-ac5e-d6eefd700389.pdf) |
| 5 Feb - Board meeting on Feb 12, 2026 to approve unaudited Q3/9M results; trading window closed. | [Board Meeting Intimation for Consideration Of Financial Result For The Quarter And Nine Months Ended 31St December, 2025 5 Feb - Board meeting on Feb 12, 2026 to approve unaudited Q3/9M results; trading window closed.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a6809344-c2ec-4a13-a8ca-6050c3192da5.pdf) |
| 4 May - Board meeting rescheduled to May 7, 2026 to approve FY26 audited results; trading window remains closed. | [Board Meeting Intimation for Rescheduling Of Board Meeting-Intimation Under Regulation 29 Of SEBI (LODR) Regulations, 2015. 4 May - Board meeting rescheduled to May 7, 2026 to approve FY26 audited results; trading window remains closed.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/5dc9abaf-d081-4fe7-9601-be40bb0f5858.pdf) |
| 4 May - Board meeting rescheduled to May 7, 2026 to approve FY26 audited results; trading window remains closed. | [Board Meeting Intimation for Rescheduling Of Board Meeting-Intimation Under Regulation 29 Of SEBI (LODR) Regulations, 2015. 4 May - Board meeting rescheduled to May 7, 2026 to approve FY26 audited results; trading window remains closed.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/5dc9abaf-d081-4fe7-9601-be40bb0f5858.pdf) |

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-08-20 | [Announcement Under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b66c9327-3352-4620-a48d-9b8a28ccfd88.pdf) |
| 2026-08-19 | [Notice Of The 44Th Annual General Meeting (AGM) And Annual Report Of The Company For The Financial Year 2025-26](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c2056100-31e3-447a-a6d2-aa81040de9a3.pdf) |
| 2026-08-19 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9100fbbb-7bce-4265-90cc-7f6f6e75969e.pdf) |
| 2026-08-17 | [Board Meeting Outcome for Outcome Of Board Meeting Held On 17.08.2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=332cd086-2fd3-4cb1-aeb0-c158f525944b.pdf) |
| 2026-08-12 | [Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29(1)(A) And Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=15151338-d242-442c-9211-aeadfdbd0c7c.pdf) |
| 2026-08-08 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=07268bb2-bb45-4149-9e85-b88427e7c4f0.pdf) |
| 2026-08-08 | [Non Applicability Of Statement Of Deviation Or Variation Under Regulation 32 Of SEBI LODR Regulations 2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1f1b8bea-6708-4f85-91f7-5156d491b7d9.pdf) |
| 2026-08-07 | [Board Meeting Outcome for Outcome Of Board Meeting To Consider And Approve Unaudited Financial Results (Standalone And Consolidated) For Quarter Ended 30Th June 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d512dc69-502c-4a98-8e51-e473efa8a4ce.pdf) |
| 2026-07-31 | [Update on board meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3d13668f-ab73-4b21-9cad-eb570a87ddd6.pdf) |
| 2026-07-28 | [Board Meeting Intimation for The Consideration And Approval Of The Quarterly Financial Result Ended On 30Th June 2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4cb3c9aa-8706-4819-a946-614becbe6ae9.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-07 | [Outcome Of Board Of Directors Meeting Of Vivanza Biosciences Limited (The Company)](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=48e1355c-b44f-4454-a9d3-fefab0f4955f.pdf) |
| 2026-08-07 | [Outcome Of Board Of Directors Meeting Of Vivanza Biosciences Limited (The Company)](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1b0ddbca-3e79-486b-8e9e-6c0a0b6e347a.pdf) |
| 2026-05-07 | [Results- Quarterly And Year To End Dated 31St March 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=23246650-c61f-4cde-9ffd-5cb0d7c5ee81.pdf) |
| 2026-02-12 | [Outcome Of The Board Meeting And Submission Of Un-Audited Financial Results For The Quarter And Nine Months Ended 31ST December 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=04f1b5b2-a13d-4cb9-9387-b851d12d8da0.pdf) |
| 2025-11-14 | [Results - Financial Results For 30Th September 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ddb39b02-a0f5-4ee3-a22b-f03392814ad9.pdf) |
| 2025-11-11 | [Financial Results For The Quarter Ended 30Th September 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2c93a1a7-8d37-49cb-b661-a3aa96f3f92d.pdf) |
| 2025-08-13 | [Financial Results For 30Th June 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0dd7edc7-6a1d-4c90-92f2-e9ba8d3fd9ea.pdf) |
| 2025-05-12 | [Board Meeting Outcome for Outcome Of Board Meeting Held Today 12Th May 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4d31f490-8bea-4857-9239-21a12f620e0c.pdf) |
| 2025-05-12 | [Audited Financial Result For The Quarter And Financial Year Ended On 31St March 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4f404a13-8b29-46bc-b83b-8d4bf00d9a31.pdf) |
| 2025-01-31 | [Results For Quarter And Nine Months Ended 31St December 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bff978ed-b087-48a4-91ce-1d697b3b6aa3.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/675f9410-7a61-4448-870b-a2953fb16187.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d7959fa8-a91d-4f05-8c8c-309ee47c0188.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f9b78999-9691-4fe2-8f27-08dc49d7d59a.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/530057/73348530057.pdf) |
| from bse | [Annual Report 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/530057/72501530057.pdf) |
| from bse | [Annual Report 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/530057/67191530057.pdf) |
| from bse | [Annual Report 2019 from bse](https://www.bseindia.com/bseplus/AnnualReport/530057/5300570319.pdf) |
| from bse | [Financial Year 2018 from bse](https://www.bseindia.com/bseplus/AnnualReport/526927/5269270318.pdf) |
| from bse | [Annual Report 2018 from bse](https://www.bseindia.com/bseplus/AnnualReport/530057/5300570318.pdf) |
| from bse | [Financial Year 2017 from bse](https://www.bseindia.com/bseplus/AnnualReport/526927/5269270317.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:48:15.246Z.